TOFACITINIB vs UPADACITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TOFACITINIB vs UPADACITINIB: Safety Overview
| Metric | TOFACITINIB | UPADACITINIB |
|---|---|---|
| Total FAERS Reports | 155,647 | 65,656 |
| Deaths Reported | 7,847 | 2,406 |
| Death Rate | 5.0% | 3.7% |
| Hospitalizations | 21,976 | 15,931 |
| Average Patient Age | 57.6 yrs | 57.4 yrs |
| % Female Patients | 81.6% | 71.2% |
| FDA Approval Date | Aug 19, 2021 | Apr 26, 2024 |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | AbbVie Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |